As per the company’s filing, this new subsidiary will be the vehicle through which Zydus plans to acquire the equity shares of Amplitude Surgical SA.

Read also: Zydus Lifesciences inks pact with PAI Partners, other shareholders to buy majority stake in Amplitude Surgical SA Zydus Lifesciences Ltd. is an innovative, global lifesciences company that ...

Read also: Zydus Lifesciences inks pact with PAI Partners, other shareholders to buy majority stake in Amplitude Surgical SA Zydus Lifesciences Ltd. is an innovative, global lifesciences company that ...

NEW DELHI: Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic version of cholesterol lowering Niacin extended-release ...

To commemorate the 25th year of the listing of Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.) on the National Stock Exchange of India (NSE), a bell ringing ceremony was organized ...

Zydus Lifesciences Ltd, on 30th April 2025, issued a press note stating that it has received the final United States Food and Drug Administration (USFDA) approval for the production and marketing ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets. The Tribune, now published from ...

On this occasion, senior management of Zydus Lifesciences, including Chairman, Pankaj R. Patel, Managing Director, Dr. Sharvil Patel, Executive Director, Ganesh Nayak and CFO, Nitin Parekh and ...

Mumbai (Maharashtra) [India], May 3: To commemorate the 25th year of the listing of Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.) on the National Stock Exchange of India (NSE ...

New Delhi: Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin ...